Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
63,600,286
-
Share change
-
+7,370,027
-
Total reported value
-
$141,258,000
-
Put/Call ratio
-
5.7%
-
Price per share
-
$2.22
-
Number of holders
-
46
-
Value change
-
+$26,684,563
-
Number of buys
-
26
-
Number of sells
-
20
Institutional Holders of AVEO PHARMACEUTICALS INC - COM (AVEO) as of Q2 2017
As of 30 Jun 2017,
AVEO PHARMACEUTICALS INC - COM (AVEO) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,600,286 shares.
The largest 10 holders included
NEA Management Company, LLC, RA CAPITAL MANAGEMENT, LLC, venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, 683 Capital Management, LLC, New Leaf Venture Partners, L.L.C., Point72 Asset Management, L.P., RENAISSANCE TECHNOLOGIES LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
46
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.